You are here

Brent Saunders

Bausch + Lomb's Saunders doesn't expect more big deals in the near term

Reuters

Fri, 08/4/23 - 10:19 am

Brent Saunders to Return as Bausch + Lomb CEO

US News Money

Wed, 02/15/23 - 10:58 am

Low-profile eye drop developer spells out the game plan that drew Brent Saunders to the board — and it involves going earlier than anti-VEGFs

Endpoints

Tue, 11/9/21 - 10:43 am

diabetic retinopathy

wet age-related macular degeneration

Vesper Healthcare Acquisition, a SPAC led by the former CEO of Allergan, files for a $400 million IPO

NASDAQ

Thu, 09/10/20 - 11:06 pm

Vesper Healthcare Acquisition

Allergan ex-CEO Saunders takes board seat at BridgeBio

Fierce Biotech

Fri, 06/26/20 - 09:54 am

Allergan CEO Saunders lines up for $39M parachute after AbbVie buy

Fierce Pharma

Wed, 08/14/19 - 07:06 pm

How Brent Saunders’ Allergan experiment failed

Stat

Wed, 06/26/19 - 10:12 am

Allergan chief Saunders takes a painful $2.5B hit on an ugly PhIII flop

Endpoints

Tue, 05/7/19 - 10:36 am

Allergan CEO Saunders hangs on to chairman's title, winning shareholder support — but not by a big enough margin to squelch critics

Endpoints

Wed, 05/1/19 - 12:23 pm

‘Something needs to change’: An Allergan analyst spells out why next week’s vote could still spark a major revamp

Endpoints

Fri, 04/26/19 - 10:27 am

Influential proxy firms kick back at activists’ demands for Brent Saunders to give up his chairman’s title at Allergan

Endpoints

Mon, 04/15/19 - 10:29 am

What do Allergan activists really want? A new CEO to replace Saunders, analyst says

Fierce Pharma

Tue, 03/5/19 - 12:03 pm

Sorry, Allergan. Another activist backs an immediate split to CEO, chairman jobs

Fierce Pharma

Fri, 03/1/19 - 08:28 pm

Under-pressure Allergan backs a CEO-chairman job split—just not right now

Fierce Pharma

Tue, 02/19/19 - 11:28 pm

What's next for embattled Allergan? Depends on pipeline performance, analysts say

Fierce Pharma

Tue, 06/19/18 - 10:57 am

Old CEO, new chairman? Some Allergan investors want Pyott to come back: report

Fierce Pharma

Mon, 06/11/18 - 05:17 pm

Saunders: All options remain on the table for Allergan

Biopharma Dive

Mon, 04/30/18 - 07:35 pm

Forget that 'no breakup' vow. Allergan's CEO now says a strategic review is happening

Fierce Pharma

Thu, 03/15/18 - 11:22 am

Lousy year for shareholders, but Allergan CEO Brent Saunders sprints past Gorsky, Gonzalez with $32M pay package

Endpoints

Wed, 03/14/18 - 11:36 am

Richard Gonzalez

Don't expect Restasis generics till at least next quarter, Allergan CEO says

Fierce Pharma

Tue, 01/9/18 - 10:52 pm

Pages